| Entry |
|
|---|
| Name |
Xylazine (USP/INN);
Chanazine (TN) |
|---|
| Formula |
C12H16N2S
|
|---|
| Exact mass |
220.1034
|
|---|
| Mol weight |
220.3338
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01449 alpha2-Adrenergic receptor agonist
|
|---|
| Remark |
|
|---|
| Efficacy |
Analgesic (veterinary), alpha2-Adrenergic receptor agonist |
|---|
| Comment |
veterinary medicine
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Animal drugs in Japan [BR:br08331]
91 Agents affecting nervous system
912 Hypnotics and sedatives
9129 Other hypnotics and sedatives
D08683 Xylazine
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01449 alpha2-Adrenergic receptor agonist
DG01321 Xylazine
D08683 Xylazine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA2
D08683 Xylazine (USP/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01449 alpha2-Adrenergic receptor agonist
DG01321 Xylazine
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 15
1 C8x C 20.5100 -16.5200
2 C8x C 20.5100 -17.9200
3 C8y C 21.7700 -18.6200
4 C8y C 22.9600 -17.9200
5 C8y C 22.9600 -16.5200
6 C8x C 21.7700 -15.8200
7 N1b N 24.2200 -18.6900
8 C1a C 24.2200 -15.8200
9 C1a C 21.7700 -20.0200
10 C2y C 25.4100 -17.9900
11 N2x N 26.6000 -18.6200
12 C1x C 27.7900 -17.9200
13 C1x C 27.7900 -16.5200
14 C1x C 26.6000 -15.8900
15 S2x S 25.4100 -16.5900
BOND 16
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 5 8 1
9 3 9 1
10 7 10 1
11 10 11 2
12 11 12 1
13 12 13 1
14 13 14 1
15 14 15 1
16 10 15 1
|
|---|
